[N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid

[N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino]-acetic acid is an experimental small molecule compound with the molecular formula C20H23N3O5 and a molecular weight of approximately 385.4 g/mol. It belongs to the class of n-acyl-alpha amino acids, which are characterized by an alpha amino acid core structure with additional acylation. The compound has been referenced in chemical and pharmacological databases but does not have any approved medical indications or known clinical use as of June 2025. Its mechanism of action is not fully established, but it has been associated in at least one database as interacting with caspase‑3, a key enzyme involved in apoptosis; however, its pharmacological action remains uncharacterized[1][2]. There are no reported clinical trials or patents for this molecule.

Other names

(N-(3-dibenzylcarbamoyl-oxiranecarbonyl)-hydrazino)-acetic acid2-(N-amino-3-(dibenzylcarbamoyl)-3-hydroxypropanamido)acetic acid2-[N-amino-3-(dibenzylcarbamoyl)-3-hydroxypropanamido]acetic acid{1-[(3S)-4-(dibenzylamino)-3-hydroxy-4-oxobutanoyl]hydrazino}acetic acid